作者: Renke Maas , Lena Dentz , Edzard Schwedhelm , Wolfgang Thoms , Oliver Kuss
DOI: 10.1097/01.CCM.0000277038.11630.71
关键词:
摘要: Objective:In patients with cardiovascular disease or organ failure, elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) are associated an increased risk future events. We aimed to investigate ADMA